Nepsis Inc’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.88M | Sell |
213,518
-11,288
| -5% | -$523K | 2.75% | 22 |
|
|
2025
Q1 | $13.7M | Buy |
+224,806
| New | +$13.7M | 3.39% | 18 |
|
|
2024
Q4 | – | Sell |
-70,768
| Closed | -$3.66M | – | 28 |
|
|
2024
Q3 | $3.66M | Buy |
70,768
+65,078
| +1,144% | +$3.37M | 0.87% | 26 |
|
|
2024
Q2 | $236K | Sell |
5,690
-230,591
| -98% | -$9.58M | 0.06% | 28 |
|
|
2024
Q1 | $12.8M | Buy |
236,281
+30,099
| +15% | +$1.63M | 3.47% | 17 |
|
|
2023
Q4 | $10.6M | Sell |
206,182
-31,894
| -13% | -$1.64M | 3.01% | 19 |
|
|
2023
Q3 | $13.8M | Buy |
238,076
+30,192
| +15% | +$1.75M | 4.23% | 15 |
|
|
2023
Q2 | $13.3M | Buy |
207,884
+3,270
| +2% | +$209K | 4.1% | 12 |
|
|
2023
Q1 | $14.2M | Buy |
204,614
+20,492
| +11% | +$1.42M | 4.72% | 9 |
|
|
2022
Q4 | $13.2M | Buy |
184,122
+4,943
| +3% | +$356K | 4.44% | 8 |
|
|
2022
Q3 | $12.7M | Sell |
179,179
-2,373
| -1% | -$169K | 4.6% | 9 |
|
|
2022
Q2 | $14M | Buy |
181,552
+8,459
| +5% | +$651K | 4.77% | 7 |
|
|
2022
Q1 | $12.6M | Sell |
173,093
-76,724
| -31% | -$5.6M | 3.77% | 17 |
|
|
2021
Q4 | $15.6M | Buy |
249,817
+32,465
| +15% | +$2.02M | 4.52% | 9 |
|
|
2021
Q3 | $12.9M | Buy |
217,352
+33,324
| +18% | +$1.97M | 4.05% | 13 |
|
|
2021
Q2 | $12.3M | Sell |
184,028
-2,790
| -1% | -$186K | 3.9% | 13 |
|
|
2021
Q1 | $11.8M | Buy |
186,818
+41,815
| +29% | +$2.64M | 3.73% | 13 |
|
|
2020
Q4 | $9M | Buy |
145,003
+6,997
| +5% | +$434K | 3.27% | 14 |
|
|
2020
Q3 | $8.32M | Buy |
138,006
+22,833
| +20% | +$1.38M | 3.99% | 9 |
|
|
2020
Q2 | $6.77M | Buy |
+115,173
| New | +$6.77M | 3.28% | 16 |
|